FreeStyle Libre 2 Plus CGM funded from 1 May 2025

Medicine update Active

Pharmac is funding a new continuous glucose monitor (CGM) – the FreeStyle Libre 2 Plus from 1 May 2025.

FreeStyle Libre 2 Plus 

The FreeStyle Libre 2 is being upgraded to the FreeStyle Libre 2 Plus

The upgrade means:

  • You can wear the FreeStyle Libre 2 Plus for 15 days. This is a day longer than the FreeStyle Libre 2.
  • It is more accurate than the FreeStyle Libre 2 

It is a standalone CGM, which means you don’t need to have an insulin pump to use it. The size, phone app, reader, adhesive, and application are the same as the FreeStyle Libre 2.

It will be funded for everyone with type 1 diabetes or type 3c diabetes. 

People will need a new prescription

People who are using the Freestyle Libre 2 will need to get a new prescription for the FreeStyle Libre 2 Plus. 

When is this happening?

The Freestyle Libre 2 Plus will be available from 1 May 2025. 

The Freestyle Libre 2 will remain funded until 1 May 2026 to give pharmacists time to claim for all dispensings.

How many people can get is changing

Because people can wear the FreeStyle Libre 2 Plus for longer, Pharmac is changing how many people can get.

Pharmac will fund a maximum of 28 FreeStyle Libre 2 Plus CGMs a year – or 6 per prescription.

Previously, people could get up to 29 FreeStyle Libre 2 CGMs a year – or 7 per prescription. 

Why is this happening?

Pharmac’s contracts with the suppliers of CGMs allow for new CGM technology to be introduced as it becomes available. Mediray/Abbott (the supplier) advised that it is discontinuing the FreeStyle Libre 2. 

Who to contact

If you have questions about this change, you can email us on enquiry@pharmac.govt.nz